A study to assess the prevalence and effect of concurrent drug therapy mentioned in Indian System of Medicine along with modern drug therapy received in patients with cardio vascular disorders.

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Adult (18-70 years) Male / Female patients visiting the Cardiology OPD.
•Participant willing to give informed consent and to come for follow up.
•Patient with coronary artery disease with or without hypertension (stage I & stage II, systolic 140â??180 and diastolic 90â??110).
•[American Heart Association]
•Patient with left ventricular dysfunction with NYHA class I& II.
•Patient taking Ayurvedic drug for any duration to assess the prevalence and taking Ayurvedic drug for the last 6 weeks to assess the effect.
•Patient should be willing to continue the same drugs as used at the time of enrollment and for the whole follow up period after 6 months.

•Patient already recruited for other trial.
•Inability to comply with the protocol or not willing to give consent.
•Pregnancy and lactation.
•Patient suffering only with Hypertension or Hypertension with CVD with
•(stage III, systolic >180 and diastolic >110)
•Patient with NYHA class III &IV.
•Past 3 months h/o or planned for re-vascularisation CABG/ PTCA in next 3 months.
•Patient who has stopped Ayurvedic drug before follow up.
•Patient with h/o unstable angina in last three months.
•Patient taking Ayurvedic drug sine more than 6 weeks to assess the effect.
•Other major organ dysfunction like renal dysfunction (Blood Urea >50 mg%, S.Creatinine >1.8 mg%) & hepatic dysfunction (AST/ ALT/ ALP/ Total S. Bilirubin > 3 times the upper normal limit )
•With other co-morbid conditions like uncontrolled diabetes mellitus, hypertension and malignancy.
•Any other condition which the investigator thinks may jeopardize the study.

发起方